A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek… - Hepatology, 2018 - journals.lww.com
Emerging studies have suggested that the Hippo pathway is involved in the tumorigenesis of
hepatocellular carcinoma (HCC). However, the key regulator of the Hippo pathway in liver …

[HTML][HTML] The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation

J Levitsky, RN Formica, RD Bloom, M Charlton… - American Journal of …, 2017 - Elsevier
The availability of direct-acting antiviral agents for the treatment of hepatitis C virus (HCV)
infection has resulted in a profound shift in the approach to the management of this infection …

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

E Mauro, G Crespo, C Montironi, MC Londoño… - …, 2018 - Wiley Online Library
Sustained virological response (SVR) improves survival in post‐liver transplant (LT)
recurrent hepatitis C. However, the impact of SVR on fibrosis regression is not well defined …

[PDF][PDF] Should organs from hepatitis C‐positive donors be used in hepatitis C‐negative recipients for liver transplantation?

N Selzner, M Berenguer - Liver Transplantation, 2018 - Wiley Online Library
Given the scarcity of donated organs and the frequency of death on the waiting list,
strategies that could improve the available supply of high‐quality liver grafts are much …

Hepatitis C transmission from seropositive, nonviremic donors to non–hepatitis C liver transplant recipients

K Bari, K Luckett, T Kaiser, T Diwan, M Cuffy… - Hepatology, 2018 - journals.lww.com
Breakthroughs in hepatitis C virus (HCV) treatment and rising rates of intravenous drug use
have led to an increase in the number of organ donors who are HCV antibody–positive but …

Occult infection with hepatitis C virus: looking for clear-cut boundaries and methodological consensus

A Wróblewska, KP Bielawski, K Sikorska - Journal of Clinical Medicine, 2021 - mdpi.com
The sustained virologic response and elimination of HCV is widely viewed as a true cure of
chronic hepatitis C as it associates with amelioration of histological liver damage and …

Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality

Y Wang, H Rao, X Chi, B Li, H Liu, L Wu, H Zhang… - …, 2019 - thelancet.com
Background Whether achieving sustained virological response (SVR) in patients with
hepatitis C attains complete elimination of hepatitis C virus (HCV) is unknown, because …

Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a …

MA Mekky, HI Sayed, MO Abdelmalek… - Infection and drug …, 2019 - Taylor & Francis
Background Occult hepatitis C virus (HCV) infection (OCI) is characterized by the detection
of HCV-RNA in non-serum reservoirs, such as peripheral blood mononuclear cells (PBMCs) …

In chronic hepatitis C infection, myeloid-derived suppressor cell accumulation and T cell dysfunctions revert partially and late after successful direct-acting antiviral …

V Telatin, F Nicoli, C Frasson, N Menegotto… - Frontiers in cellular …, 2019 - frontiersin.org
Chronic HCV infection is characterized by several immunological alterations, such as the
accumulation of suppressor cells and of hyperactivated T lymphocytes. However, it is …

Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C

M Enomoto, Y Ikura, A Tamori… - United European …, 2018 - journals.sagepub.com
Background Interferon-free, direct-acting antiviral treatments can result in a sustained
virologic response in nearly 100% of patients with chronic hepatitis C virus infection. Aims …